Pathstone Family Office
ACLS icon

Pathstone Family Office’s Axcelis ACLS Stock Holding History

Pathstone Family Office’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$218K Buy
+1,336
New +$235K ﹤0.01% 1461

Other funds holding ACLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Whale Rock Capital Management
Whale Rock Capital Management Boston, Massachusetts $12.5B AUM 306.52% 1-Year Est. Return

Pathstone Family Office's ACLS Position: Q3 2023 in Review

Pathstone Family Office opened a new position in Axcelis (ACLS) in Q3 2023: 1,336 shares worth $218K. The stake represents ﹤0.01% of the portfolio and ranks #1461 among its holdings.

420 funds tracked by Wall St. Rank hold ACLS as of Q3 2023.

  • Pathstone Family Office held 1,336 shares of Axcelis worth $218K as of Q3 2023.
  • Axcelis was a new Pathstone Family Office position in Q3 2023.
  • Axcelis made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1461 holding.
  • 420 funds tracked by Wall St. Rank held Axcelis as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.